Hivus LR (Lopinavir+Ritonavir) Tablet

Generic brands for Lopinavir+Ritonavir Injection  Available in India Brand Name Hivus LR Generic Name Lopinavir+Ritonavir Strength Manufacturer Aurobindo Pharma Limited

Description

Description

This page contains brief details about the drug lopinavir,ritonavir, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Lopinavir, Ritonavir is a combination of antiretroviral medicine developed by the U.S. Food And Drug Administration for treating HIV-1 infection.

Mechanism of Action of Lopinavir+Ritonavir

Lopinavir and Ritonavir work together to inhibit the protease enzyme, which is necessary for the replication of HIV. By blocking this enzyme, this drug prevents the virus from multiplying and spreading in the body. It mainly helps reduce the viral load and slow the progression of HIV infection.

Uses of Lopinavir+Ritonavir

Lopinavir, Ritonavir are used to treat Human Immunodeficiency Virus (HIV) in adults and adolescents over 12 who weigh at least 40 kg. HIV infection occurs when a person’s immune system is attacked and weakened by the human immunodeficiency virus (HIV). This infection progressively weakens the immune system, making individuals more susceptible to opportunistic infections.

Lopinavir+Ritonavir Dosage available

It is an orally available prescription drug. Your doctor will decide the dose and duration of the drug based on the disease condition and other factors. Always take Lopinavir and Ritonavir as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.

 

News/Updates

References

  1. AbbVie Deutschland GmbH & Co. KG, Electronic medicines compendium (EMC), [ Revised on March 2021] [ Accessed on 17th May 2023], https://www.medicines.org.uk/emc/files/pil.221.pdf
  2. AbbVie Inc, US Food and Drug Administration, [ Revised on December 2018] [ Accessed on 17th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/090371PI.pdf
  3. KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th edition, 2013, 809 – 811.
  4. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th edition, 2011, 1645-1654.